EUVIMEDEUVIMED entdecken
Crossref

Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker

Stephanie N Hurwitz, Brian Lockhart, Özlem Önder, Rui Wu, Shenon Sethi, Umut Aypar, Reiner Siebert, Ahmet Dogan, Vinodh Pillai, Kojo S J Elenitoba-Johnson, Megan S Lim

Modern Pathology · 2023

DOI: 10.1016/j.modpat.2023.100170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Stephanie N Hurwitz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Proteogenomics, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: NCI NIH HHS, Universität Ulm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkitt LymphomaProteogenomicsLymphoma, B-CellLymphoma, Large B-Cell, DiffuseHumansLymphoid Enhancer-Binding Factor 1ProteomicsChromosome AberrationsBiomarkers

Stichwörter der Autor:innen

11q aberrationB-cell lymphomabiomarkermass spectrometrytranscriptomic

Substanzen

Lymphoid Enhancer-Binding Factor 1Biomarkers

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
  • Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia…

Förderung

  • NCI NIH HHS
  • Universität Ulm

Zitieren

APA

Hurwitz, S. N., Lockhart, B., Önder, Ö., Wu, R., Sethi, S., Aypar, U., Siebert, R., Dogan, A., Pillai, V., Elenitoba-Johnson, K. S. J., & Lim, M. S. (2023). Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100170

Vancouver

Hurwitz SN, Lockhart B, Önder Ö, Wu R, Sethi S, Aypar U, et al. Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker. Modern Pathology. 2023. doi:10.1016/j.modpat.2023.100170

BibTeX
@article{Hurwitz2023,
  author = {Hurwitz, Stephanie N and Lockhart, Brian and Önder, Özlem and Wu, Rui and Sethi, Shenon and Aypar, Umut and Siebert, Reiner and Dogan, Ahmet and Pillai, Vinodh and Elenitoba-Johnson, Kojo S J and Lim, Megan S},
  title = {Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker},
  journal = {Modern Pathology},
  year = {2023},
  doi = {10.1016/j.modpat.2023.100170}
}
Kostenlos starten →